Aaron B. Beasley

Perth, WA 6027, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in Bladder Cancer.

Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in Bladder Cancer.

Journal: Archivos espanoles de urologia

Published: March 03, 2026

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State.

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State.

Journal: Investigative ophthalmology & visual science

Published: January 27, 2026

GWAS meta-analysis provides new insights into uveal melanoma risk.

GWAS meta-analysis provides new insights into uveal melanoma risk.

Journal: British journal of cancer

Published: December 04, 2025

Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives.

Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives.

Journal: Neuro-oncology advances

Published: July 03, 2025

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.

Journal: Cancer cell international

Published: April 01, 2025

Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014).

Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014).

Journal: Investigative ophthalmology & visual science

Published: November 01, 2023

Detection of metastases using circulating tumour DNA in uveal melanoma.

Detection of metastases using circulating tumour DNA in uveal melanoma.

Journal: Journal of cancer research and clinical oncology

Published: June 13, 2023

Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.

Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.

Journal: ESMO open

Published: May 15, 2023

Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer.

Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer.

Journal: Clinical chemistry

Published: April 18, 2023

Locally performed postoperative circulating tumour DNA testing performed during routine clinical care to predict recurrence of colorectal cancer.

Locally performed postoperative circulating tumour DNA testing performed during routine clinical care to predict recurrence of colorectal cancer.

Journal: ANZ journal of surgery

Published: January 19, 2023

Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?

Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?

Journal: Seminars in cancer biology

Published: November 08, 2022

Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones.

Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones.

Journal: Nature communications

Published: October 05, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026